Parameter | n | Total urate deposit score correlation coefficient |
---|---|---|
Age | 55 | −0.23 |
p-value | 0.09 | |
Disease duration, years | 55 | 0.64 |
p-value | <.0001 | |
Urate at DECT | 55 | −0.12 |
p-value | 0.36 | |
n | Total urate deposit score, mean | |
Age categories | 55 | |
< 65 years | 24 | 13.6 (5.8) |
> 65 years | 31 | 14.4 (5.3) |
p-value | 0.5 | |
Gender | 55 | |
Men | 43 | 13.5 (5.4) |
Women | 12 | 16.1 (5.4) |
p-value | 0.09 | |
Tophus | 55 | |
Yes | 7 | 21.1 (3.2) |
No | 48 | 13.0 (5.0) |
p-value | 0.0005 | |
Erosive disease | 55 | |
Yes | 36 | 14.3 (5.6) |
No | 19 | 13.6 (5.6) |
p-value | 0.7 | |
Presence of nail artifacts | 55 | |
Yes | 40 | 14.3 (4.0) |
No | 15 | 13.5 (4.5) |
p-value | 0.7 | |
Presence of skin artifacts | 55 | |
Yes | 17 | 15.6 (5.3) |
No | 38 | 13.3 (5.5) |
p-value | 0.2 | |
Disease duration, years | 55 | |
Short ≤7 | 35 | 11.9 (4.8) |
Long > 7 | 20 | 17.8 (4.6) |
p-value | 0.0002 | |
Urate at DECT | 55 | |
≤ 405 μmol/L | 19 | 15.1 (5.5) |
> 405 μmol/L | 36 | 13.5 (5.5) |
p-value | 0.18 | |
ULT use at DECT | 55 | |
Yes | 22 | 14.9 (5.4) |
No | 33 | 13.5 (5.5) |
p-value | 0.2 | |
Diuretic use | 55 | |
Yes | 16 | 13.9 (5.1) |
No | 39 | 14.1 (5.7) |
p-value | 0.8 | |
BMI | 42 | |
< 30 | 22 | 13.6 (6.1) |
≥ 30 | 20 | 13.4 (5.4) |
p-value | 0.9 | |
Renal function by eGFR | 55 | |
≥ 90 | 16 | 13.8 (5.2) |
60–90 | 20 | 12.8 (5.3) |
< 60 | 19 | 15.5 (5.8) |
p-value | 0.4 |